Dr. Meaghan Jones is an Assistant Professor at the Department of Biochemistry and Medical Genetics in the University of Manitoba, and an Investigator at the Children's Hospital Research Institute of Manitoba.

This interview, co-hosted by Sarah Dada and Dr. Benjamin Lebeau, focuses on Dr. Jones' career studying how a mother's smoke exposure can affect children.

Dr. Federico Gaiti is a scientist at Princess Margaret Cancer Center and Assistant Professor at the University of Toronto. In this episode, he shares his career path and his current research on how epigenetics shapes brain cancer biology.

Dr. Carolyn Brown is a Professor in the Department of Medical Genetics at the University of British Columbia and a world-renowned expert on X-chromosome inactivation. In this episode, co-hosted by Edward Gardner and Sanne Janssen, Dr. Brown shares with us why calico cats are cool, the exciting discovery of Xist, and valuable tips for young scientist.

Dr. McGraw est Professeur adjoint sous-octroi au Centre de Recherche CHU Ste-Justine affilié à l’Université de Montréal. Cette entrevue, coanimée par Ariane Lismer et Benjamin Lebeau, se concentre sur le parcours académique du Dr. McGraw et sur l’étude de l’influence des habitudes de vie des parents sur le développement embryonnaire de leurs enfants.

This interview, co-hosted by Edward Gardner and Sanne Janssen, focusses on Dr. Dilworth’s hobbies, career advice for scientists, and the epigenetics of muscle cells.

Dr. Lupien est Professeur à l’Université de Toronto et Scientifique Sénior au Princess Margaret Cancer Centre. Cette entrevue, coanimée par Ariane Lismer et Benjamin Lebeau, se concentre sur le parcours académique du Dr. Lupien et sur les liens étroits entre les changements de la chromatine et l’évolution et la progression du cancer.

Dr. Martin Hirst is Head of Epigenomics at Canada’s Michael Smith Genome Sciences Centre, Director of the Michael Smith Laboratory and Professor at the University of British Columbia. 

This interview, co-hosted by Alvin Qiu and Benjamin Lebeau, focuses on Dr. Hirst’s career and future perspectives on epigenetic approaches for cancer therapy.